Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$12,437,299
-$1,600,120 QoQ
Shares Held
79,360
-13.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#153
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $293,455,653 across 12 Drug Manufacturers - General names. NVS ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
336,097 | $84,575,449 | |
| 2 | JNJ |
Johnson & Johnson
|
258,233 | $65,583,435 | |
| 3 | MRK |
Merck & Co., Inc.
|
447,832 | $57,546,412 | |
| 4 | LLY |
ELI LILLY & Co
|
24,659 | $29,576,746 | |
| 5 | NVS |
Novartis AG
This page
|
79,360 | $12,437,299 | |
| 6 | PFE |
Pfizer Inc
|
465,004 | $11,197,296 | |
| 7 | SNY |
Sanofi
|
195,567 | $8,342,888 | |
| 8 | AMGN |
Amgen Inc
|
21,433 | $7,761,317 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,437,299 | 79,360 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $14,037,419 | 91,898 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $15,832,301 | 114,835 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $14,863,272 | 115,902 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,075,157 | 116,314 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,098,119 | 117,493 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $11,571,424 | 118,913 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $12,366,720 | 107,518 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $11,739,982 | 110,276 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $10,498,977 | 108,539 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $10,908,394 | 108,036 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $11,739,466 | 115,251 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $11,565,396 | 114,611 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $16,396,608 | 178,224 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $16,449,441 | 181,321 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $13,786,617 | 181,379 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $15,609,309 | 184,660 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $16,220,763 | 184,852 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,876,199 | 192,937 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $20,453,259 | 250,101 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $22,989,195 | 251,964 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $25,444,575 | 297,667 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $29,017,866 | 307,295 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $27,283,265 | 313,745 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $27,950,372 | 320,018 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $23,295,670 | 282,543 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||